Integrating a Mental Health Intervention Into Primary Health Care for Refugees
Primary Purpose
Medication Adherence, Mental Health Issue, Self Efficacy
Status
Recruiting
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
Common Elements Treatment Approach
Sponsored by
About this trial
This is an interventional treatment trial for Medication Adherence
Eligibility Criteria
Inclusion Criteria:
A. Inclusion criteria:
- Patients who was diagnosed by physician based on ICD 10 to have diabetes, hypertension or diabetes with hypertension comorbidity, or epilepsy.
- Registered in chronic database system of the camp.
B. Exclusion criteria:
- who are younger than 18 years old
- who have severe physical illness
- who have severe mental disorders
- who will not stay in the camp until the end of the program
- who are not willing to participate in the program
Exclusion Criteria:
-
Sites / Locations
- Mae La Refugee CampRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention Arm
Waitlisted Arm
Arm Description
The course of Common Elements Treatment Approach (CETA - the intervention under study) is built to be flexible depending on need. Mild symptoms could result in fewer sessions (e.g., 5), while greater severity may require 8-12 sessions.
The waitlisted arm will be offered the CETA approach upon conclusion of the endline data collection.
Outcomes
Primary Outcome Measures
Medication Adherence Report Scale
Medication Adherence - Self Report will be assessed using the 5-item Medication Adherence Report Scale (MARS-5). Each item assesses the frequency of deviations in medication use, ranging from never (0) to all days (4) over the past two weeks. The MARS-5 will be scored by calculating the mean of all items to generate a continuous score ranging from 0-4, with higher scores indicating greater problems with medication adherence.
Pill Count Medication Adherence
Medication Adherence - Pill Count: Measurement: Medication Adherence will also be objectively measured by counting the proportion of pills taken over the past two weeks relative to the number taken if used as prescribed over the same period. Proportions will range from 0-100% with higher proportion indicating greater adherence. Proportions will be used to classify a binary indicator of adherence using an 80% or higher cutoff.
Secondary Outcome Measures
Full Information
NCT ID
NCT05512624
First Posted
May 15, 2022
Last Updated
December 20, 2022
Sponsor
International Rescue Committee
Collaborators
Khon Kaen University, Johns Hopkins University
1. Study Identification
Unique Protocol Identification Number
NCT05512624
Brief Title
Integrating a Mental Health Intervention Into Primary Health Care for Refugees
Official Title
Integrating an Evidence-based Mental Health Intervention Into Primary Health Care to Improve Outcomes for Refugees With Hypertension, Diabetes, and Epilepsy
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2022 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
September 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
International Rescue Committee
Collaborators
Khon Kaen University, Johns Hopkins University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of this study is to evaluate the impact of an evidence-based mental health intervention (Common Elements Treatment Approach) on medication adherence, behavioral improvement and clinical outcomesamong adults taking medication for hypertension, diabetes and epilepsy using a two-arm randomized wait-list controlled trial among adult refugees in Mae La camp, Thailand.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Medication Adherence, Mental Health Issue, Self Efficacy, Hypertension, Epilepsy, Diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two-armed randomized waitlisted control trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
308 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
The course of Common Elements Treatment Approach (CETA - the intervention under study) is built to be flexible depending on need. Mild symptoms could result in fewer sessions (e.g., 5), while greater severity may require 8-12 sessions.
Arm Title
Waitlisted Arm
Arm Type
No Intervention
Arm Description
The waitlisted arm will be offered the CETA approach upon conclusion of the endline data collection.
Intervention Type
Behavioral
Intervention Name(s)
Common Elements Treatment Approach
Intervention Description
For treatment group participants, they will then have weekly meetings with a counselor lasting no more than 1.5 hours per session, and a total of approximately 10 sessions. Both treatment and wait list participants will then complete the assessment instrument at 3 months and 6 months post-enrollment (each lasting no more than 1.5 hours). All total, it is expected that treatment group participants will have up to 13 meetings with a study team member or counselor over the course of their participation.
Wait list group participants will have 3 meetings with a study team member over the course of their participation. If the treatment is deemed to be effective these wait list participants will be the first adults to be offered the intervention after trial completion.
Primary Outcome Measure Information:
Title
Medication Adherence Report Scale
Description
Medication Adherence - Self Report will be assessed using the 5-item Medication Adherence Report Scale (MARS-5). Each item assesses the frequency of deviations in medication use, ranging from never (0) to all days (4) over the past two weeks. The MARS-5 will be scored by calculating the mean of all items to generate a continuous score ranging from 0-4, with higher scores indicating greater problems with medication adherence.
Time Frame
Baseline, Endline, Past two weeks
Title
Pill Count Medication Adherence
Description
Medication Adherence - Pill Count: Measurement: Medication Adherence will also be objectively measured by counting the proportion of pills taken over the past two weeks relative to the number taken if used as prescribed over the same period. Proportions will range from 0-100% with higher proportion indicating greater adherence. Proportions will be used to classify a binary indicator of adherence using an 80% or higher cutoff.
Time Frame
Baseline, Endline, Past two weeks
Other Pre-specified Outcome Measures:
Title
Substance use
Description
two locally developed items each assessing self-reported use of alcohol, tobacco, and betel nut. The first question for each substance assesses frequency of use, ranging from never (0) to all days (4) over the past two weeks. The second item is open-ended to record self-reported daily average intake (drinks/smokes/betels per day). Separate consumption scores will be generated for each of alcohol, tobacco, and betel by multiplying the frequency range (0-4) by the average intake to generate a continuous numeric quantifier of recent consumption, with higher scores reflecting greater consumption.
Time Frame
Baseline, Endline, Past two weeks
Title
Physical activity
Description
Three locally developed items assessing frequency of physical activities (vigorous, moderate, and leisure) for at least 30 minutes, ranging from never (0) to all days (4) over the past two weeks. A composite score will be calculated by taking the mean of all 3 items , for a total score ranging from 0-4 with higher scores indicating greater frequency of physical activity.
Time Frame
Baseline, Endline, Past two weeks
Title
Diet
Description
Three locally developed items assessing frequency of unhealthy food consumption (sugary, fatty, and salty foods), ranging from never (0) to all days (4) over the past two weeks. A composite score will be calculated by taking the mean of all 3 items, for a total score ranging from 0-4 with higher scores indicating greater consumption of unhealthy foods.
Time Frame
Baseline, Endline, Past two weeks
Title
Sleep Quality
Description
Sleep quality will be assessed using the 6-item sleep scale from the Medical Outcomes Study (MOS-6). Items assess frequency of experiencing a range of positive (2 items) and problematic (4 items) sleep experiences, ranging from none of the time (0) to all of the time (4) over the past two weeks. The MOS-6 will be scored by first reverse-scoring the two positively worded items, then calculating the mean of all items to generate a continuous score ranging from 0-4, with higher scores indicating poorer sleep patterns.
Time Frame
Baseline, Endline, Past two weeks
Title
Mental Health Symptoms
Description
The Myanmar-Wide Short Version of the International Depression Symptom Scale (IDSS) is comprised of 15 scored items (additional items are assessed for clinical relevance but not included in scoring) assessing symptoms of depression, anxiety, and post-traumatic stress. Each item assesses frequency of experiencing the symptom over the past two weeks, ranging from none of the time (0) to all of the time (3). The IDSS is scored by taking the mean of all items to generate a continuous distress score ranging from 0-3, with higher scores indicating greater distress.
Time Frame
Baseline, Endline, Past two weeks
Title
Disease management self-efficacy
Description
Disease management self-efficacy will be assessed using a 9-item scale measuring self-reported confidence in taking various actions to manage one's illness, ranging from not confident at all (0) to fully confident (3). Scores will be calculated by taking the mean of all items to generate a continuous score ranging from 0-3, with higher scores indicating greater self-efficacy in managing chronic disease.
Time Frame
Baseline, Endline, Past two weeks
Title
Non hypertensive blood pressure
Description
Proportion of individuals who do not have hypertension among the subsample who were hypertensive. Higher proportion is better. Both systolic and diastolic blood pressures will be used.
Time Frame
Baseline, Endline, present
Title
HbA1C change
Description
Proportion of those who could control gluclose in red blood cell (A1C < 6.5) between intervention and control groups. Higher proportion is better. For diabetic subsample
Time Frame
Baseline, endline, present
Title
Fasting plasma glucose
Description
Proportion difference of those who could control fasting plasma glucose (FPG<120) of those who could control glucose in red blood cell (AIC<6.5) between intervnetion and comparison gropu. Higher proportion is better. For diabetic subsample
Time Frame
Baseline, endline, present.
Title
Incidence of seizure
Description
For epileptic patients, incidence rate ratio of seizures between intervention and comparison groups.
Time Frame
Baseline, Endline, present.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
A. Inclusion criteria:
Patients who was diagnosed by physician based on ICD 10 to have diabetes, hypertension or diabetes with hypertension comorbidity, or epilepsy.
Registered in chronic database system of the camp.
B. Exclusion criteria:
who are younger than 18 years old
who have severe physical illness
who have severe mental disorders
who will not stay in the camp until the end of the program
who are not willing to participate in the program
Exclusion Criteria:
-
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ye Htut Oo
Phone
(202) 822-0043
Email
yehtut.oo@rescue.org
First Name & Middle Initial & Last Name or Official Title & Degree
Kathryn Falb
Phone
(202) 822-0043
Email
kathryn.falb@rescue.org
Facility Information:
Facility Name
Mae La Refugee Camp
City
Mae Sot
Country
Thailand
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ye Htut Oo
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Integrating a Mental Health Intervention Into Primary Health Care for Refugees
We'll reach out to this number within 24 hrs